MedPath

Ketamine for Postoperative Pain in Bariatric Surgery

Phase 4
Conditions
Bariatric Surgery Candidate
Pain, Postoperative
Interventions
Drug: Saline
Registration Number
NCT03389022
Lead Sponsor
Lithuanian University of Health Sciences
Brief Summary

The aim of this study was to evaluate an effect of pre - incisional single injection of low-dose ketamine on postoperative pain after remifentanil infusion in patients undergoing laparoscopic gastric bypass and gastric plication surgery. Ketamine is an old general anaesthetic. Low doses of it might be used as a adjunct in postoperative analgesia.The investigators expect that the low-dose ketamine reduces postoperative pain after bariatric surgeries.

Detailed Description

Effective postoperative pain management enhances early postoperative rehabilitation and may improve outcomes of surgical treatment. New analgetic medications and combinations of these are sought for optimal analgesia with lowest possible incidence of side effects. One of the method of multimodal analgesia is a combination of opioids and adjuvant agents, such as ketamine. To our knowledge, the role of ketamine in the treatment of postoperative pain after bariatric surgeries is poorly researched. The investigators hypothesize that ketamine, acting through the N-methyl-D-aspartate receptor (NMDA) and opioid receptors, provides favourable conditions for adequate post-operative pain management.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
64
Inclusion Criteria
  • II or III The American Society of Anesthesiologists (ASA) physical status
  • age > 18 years
  • bariatric surgery with general remifentanil anesthesia
Exclusion Criteria
  • anamnesis of using opioids for the treatment of chronic pain
  • opioid dependence
  • younger than 18 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlSalineThe same amount of intravenous single pre-incisional injection of saline for bariatric patients in the operating room.
Treatment1Ketamine0,15 mg/kg (LBM) of intravenous pre-incisional single bolus injection of ketamine given for bariatric patients in the operating room.
Treatment2Ketamine0,3 mg/kg (LBM) of intravenous pre-incisional single bolus injection of ketamine given for bariatric patients in the operating room.
Treatment3Ketamine0,15 mg/kg (LBM) of intravenous pre-incisional single bolus injection, followed by continuous infusion of 1mg/kg ketamine given for bariatric patients in the operating room.
Treatment4Ketamine0,3 mg/kg (LBM) of intravenous pre-incisional single bolus injection, followed by continuous infusion of 1mg/kg ketamine given for bariatric patients in the operating room.
Primary Outcome Measures
NameTimeMethod
Postoperative pain intensityOn the first postoperative day

Comparison of pain intensity will be recorded in both groups every 15 min in Post Anesthesia Care Unit (PACU) for 2.5 hours. Postoperative pain was treated with boluses of i.v. morphine (3 mg) at 3 min. intervals on request, if pain intensity exceeded the score of 5 according to the Numeric Pain Rating Scale (NPRS) (0-10). After the transfer of patient's to a regular unit, pain intensity was recorded every 6 hours.

Postoperative morphine requirementsOn the first postoperative day

Postoperative morphine requirements will be recorded in both groups in the PACU for 2.5 hours.

Secondary Outcome Measures
NameTimeMethod
Incidence of side effectsOn the first postoperative day

Incidence of side effects will be recorded in both groups on the first postoperative day.

Patients' satisfaction with postoperative analgesiaOn the second postoperative day

Patients' satisfaction with postoperative analgesia will be recorded in both groups on the second postoperative day.The subject could express their level of satisfaction in five possible levels, from "very satisfied" to "very dissatisfied".

© Copyright 2025. All Rights Reserved by MedPath